{
    "title": "BioNTech completes Phase II trial of COVID-19 vaccine in China",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10801613/BioNTech-completes-Phase-II-trial-COVID-19-vaccine-China.html",
    "date": "2022-05-10",
    "keywords": [
        "vaccine",
        "china",
        "beijing",
        "biontech",
        "phase",
        "trial",
        "covid19",
        "mrna",
        "developer",
        "january",
        "registry",
        "messenger",
        "rna",
        "technology",
        "worldwide",
        "covid",
        "approval",
        "population",
        "zerocovid",
        "time",
        "step",
        "vaccination",
        "battle",
        "country",
        "outbreak",
        "application",
        "authorization",
        "bnt162b2",
        "mainland",
        "data",
        "package",
        "spokesperson",
        "company",
        "decision",
        "safety",
        "immunogenicity",
        "database",
        "agency",
        "health",
        "shanghai",
        "group",
        "co",
        "partner",
        "request",
        "comment",
        "reporting",
        "roxanne",
        "liu",
        "patricia",
        "weiss",
        "frankfurt",
        "editing",
        "clarence",
        "fernandez",
        "osmond"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}